NEURONETICS INC (STIM) Stock Price & Overview
NASDAQ:STIM • US64131A1051
Current stock price
The current stock price of STIM is 1.59 USD. Today STIM is up by 6%. In the past month the price increased by 9.28%. In the past year, price decreased by -64.51%.
STIM Key Statistics
- Market Cap
- 110.632M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.59
- Dividend Yield
- N/A
STIM Stock Performance
STIM Stock Chart
STIM Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to STIM. When comparing the yearly performance of all stocks, STIM is a bad performer in the overall market: 94.2% of all stocks are doing better.
STIM Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to STIM. STIM may be in some trouble as it scores bad on both profitability and health.
STIM Earnings
On March 17, 2026 STIM reported an EPS of -0.1 and a revenue of 41.78M. The company beat EPS expectations (8.09% surprise) and beat revenue expectations (0.72% surprise).
STIM Forecast & Estimates
9 analysts have analysed STIM and the average price target is 4.42 USD. This implies a price increase of 177.99% is expected in the next year compared to the current price of 1.59.
For the next year, analysts expect an EPS growth of 17.59% and a revenue growth 9.73% for STIM
STIM Groups
Sector & Classification
STIM Financial Highlights
Over the last trailing twelve months STIM reported a non-GAAP Earnings per Share(EPS) of -0.59. The EPS increased by 56.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.55% | ||
| ROE | -174.27% | ||
| Debt/Equity | 2.94 |
STIM Ownership
STIM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 14.59 | 161.117B | ||
| ISRG | INTUITIVE SURGICAL INC | 41.46 | 160.285B | ||
| SYK | STRYKER CORP | 21.78 | 125.349B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.6 | 88.457B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.06 | 45.956B | ||
| IDXX | IDEXX LABORATORIES INC | 39.06 | 45.191B | ||
| BDX | BECTON DICKINSON AND CO | 11.4 | 44.616B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.81 | 32.972B | ||
| RMD | RESMED INC | 18.08 | 32.227B | ||
| DXCM | DEXCOM INC | 24.93 | 24.092B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 17.942B | ||
| PODD | INSULET CORP | 29.86 | 13.321B | ||
| PEN | PENUMBRA INC | 65.18 | 12.858B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About STIM
Company Profile
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. The company is headquartered in Malvern, Pennsylvania. The company went IPO on 2018-06-28. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The firm provides more than 7.1 million treatments to over 1,95,000 patients.
Company Info
IPO: 2018-06-28
NEURONETICS INC
3222 Phoenixville Pike
Malvern PENNSYLVANIA 19355 US
CEO: Keith J. Sullivan
Employees: 658
Phone: 18776007555
NEURONETICS INC / STIM FAQ
What does NEURONETICS INC do?
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. The company is headquartered in Malvern, Pennsylvania. The company went IPO on 2018-06-28. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The firm provides more than 7.1 million treatments to over 1,95,000 patients.
What is the stock price of NEURONETICS INC today?
The current stock price of STIM is 1.59 USD. The price increased by 6% in the last trading session.
Does STIM stock pay dividends?
STIM does not pay a dividend.
What is the ChartMill rating of NEURONETICS INC stock?
STIM has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is NEURONETICS INC (STIM) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on STIM.
When does NEURONETICS INC (STIM) report earnings?
NEURONETICS INC (STIM) will report earnings on 2026-05-04.
Who owns NEURONETICS INC?
You can find the ownership structure of NEURONETICS INC (STIM) on the Ownership tab.